Back
Summit Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
65
SMMT
Summit Therapeutics
Last Price:
21.41
Seasonality Move:
43.75%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20 | Buy |
| 20-day SMA: | 20.63 | Buy |
| 50-day SMA: | 20.55 | Buy |
| 200-day SMA: | 9.96 | Buy |
| 8-day EMA: | 20.63 | Buy |
| 20-day EMA: | 20.49 | Buy |
| 50-day EMA: | 19.23 | Buy |
| 200-day EMA: | 11.98 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 54.59 | Buy |
| Chaikin Money Flow: | 421167 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.05 - 21.57) | Buy |
| Bollinger Bands (100): | (9.09 - 21.39) | Buy |
Summit Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 21.41 while SMMT 8-day simple moving average is 20.00, which is a Buy signal.
- The stock price of SMMT is 21.41 while Summit Therapeutics 20-day SMA is 20.63, which makes it a Buy.
- Summit Therapeutics 50-day simple moving average is 20.55 while SMMT share price is 21.41, making it a Buy technically.
- SMMT stock price is 21.41 and Summit Therapeutics 200-day simple moving average is 9.96, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
65
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a Buy
The current Summit Therapeutics [SMMT] share price is $21.41. The Score for SMMT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
15.79B
Price in USD:
21.41
Share Volume:
1.73M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
1.75
Buy
65
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?
The Summit Therapeutics stock price is 21.41 USD today. -
Will SMMT stock go up or go down?
Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Summit Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 21.41 while SMMT 8-day exponential moving average is 20.63, which is a Buy signal.
- The stock price of SMMT is 21.41 while Summit Therapeutics 20-day EMA is 20.49, which makes it a Buy.
- Summit Therapeutics 50-day exponential moving average is 19.23 while SMMT share price is 21.41, making it a Buy technically.
- SMMT stock price is 21.41 and Summit Therapeutics 200-day simple moving average is 11.98, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
- SMMT Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Summit Therapeutics is a Buy
- Summit Therapeutics Relative Strength Index (RSI) is 54.59, which suggest Summit Therapeutics is overbought
- The Bollinger Bands (25) for Summit Therapeutics is (19.05 - 21.57), which suggest Summit Therapeutics is a Buy
- The Bollinger Bands (100) for Summit Therapeutics is (9.09 - 21.39), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.